Blueprint Medicines Corp (NASDAQ:BPMC)

92.31
Delayed Data
As of 3:59pm ET
 -3.30 / -3.45%
Today’s Change
43.29
Today|||52-Week Range
125.61
-17.69%
Year-to-Date
Blueprint Medicines (BPMC) Gets EMA Validation for Ayvakyt in SM
Mar 04 / Zacks.com - Paid Partner Content